Veracyte Inc (VCYT)

Net profit margin

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Net income US$ in thousands 24,138 -74,404 -36,560 -75,563 -35,847
Revenue US$ in thousands 445,764 361,051 296,536 219,514 117,483
Net profit margin 5.41% -20.61% -12.33% -34.42% -30.51%

December 31, 2024 calculation

Net profit margin = Net income ÷ Revenue
= $24,138K ÷ $445,764K
= 5.41%

The net profit margin of Veracyte Inc. exhibits a notable evolution over the period from December 31, 2020, to December 31, 2024. Initially, the company reported a substantial negative net profit margin of -30.51% in 2020, indicating significant losses relative to revenue. The margin further declined in 2021 to -34.42%, reflecting a worsening profitability position during that year. In 2022, the negative margin improved markedly to -12.33%, suggesting a stride toward reducing losses and potentially operational improvements. However, in 2023, the net profit margin reverted to a more negative figure of -20.61%, signaling a setback or increased expenses affecting profitability. Notably, in the latest reporting period of 2024, the company achieved a positive net profit margin of 5.41%, indicating that Veracyte Inc. transitioned into profitability with net income exceeding expenses. Overall, this trend reflects a substantial recovery and transformational shift toward profitability within the four-year span.